UNSPSC 51273920: Benzocaine/resorcinol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273920 Benzocaine/resorcinol, a Commodity code, shows minimal alignment between its nominal scope and recent state and local solicitation activity. The code's abstract name suggests pharmaceutical chemical compounds used in topical anesthetics and antiseptics, yet the three most recent opportunities posted under or near this code involve naloxone (an opioid reversal agent), multi-source generic pharmaceuticals and OTC products supplied through authorized wholesalers, and direct-to-manufacturer prescription program capabilities — none of which are benzocaine or resorcinol formulations. State and local governments appear to be tagging pharmaceutical procurement broadly under this code, likely due to classification inconsistencies in the submitting agencies' taxonomy systems rather than because benzocaine or resorcinol itself is the subject of current demand.

The issuing bodies span county health departments, state HHS commissions, and multi-state cooperative purchasing alliances. Seminole County, Florida (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding; the Texas Health and Human Services Commission (RFI HHS0017013, posted April 3, 2026) conducted a market-intelligence inquiry on direct pharmaceutical manufacturer contracting; and the Minnesota Multistate Cooperative Purchasing Alliance (S1070000015802, posted January 20, 2026, due March 26, 2026) issued an RFP for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers to multiple state and local facilities, including Oregon. Recent activity concentrates in Florida, Texas, and Minnesota, with multi-state reach through cooperative purchasing. Because recent opportunities do not reflect true demand for benzocaine or resorcinol products, firms pursuing this code should verify with issuing agencies whether their products align with actual procurement intent or whether the code assignment reflects administrative misclassification.